B. Kenneth Koe

5.6k total citations · 3 hit papers
79 papers, 4.7k citations indexed

About

B. Kenneth Koe is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, B. Kenneth Koe has authored 79 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 30 papers in Organic Chemistry and 30 papers in Cellular and Molecular Neuroscience. Recurrent topics in B. Kenneth Koe's work include Neuroscience and Neuropharmacology Research (22 papers), Neurotransmitter Receptor Influence on Behavior (18 papers) and Receptor Mechanisms and Signaling (16 papers). B. Kenneth Koe is often cited by papers focused on Neuroscience and Neuropharmacology Research (22 papers), Neurotransmitter Receptor Influence on Behavior (18 papers) and Receptor Mechanisms and Signaling (16 papers). B. Kenneth Koe collaborates with scholars based in United States and Canada. B. Kenneth Koe's co-authors include Albert Weissman, S. S. Tenen, Lorraine A. Lebel, Reinhard Sarges, Ronald G. Browne, A. Weissman, Harry Howard, James Heym, Willard M. Welch and W. M. WELCH and has published in prestigious journals such as Nature, Science and Journal of the American Chemical Society.

In The Last Decade

B. Kenneth Koe

77 papers receiving 4.4k citations

Hit Papers

p-CHLOROPHENYLALANINE: A SPECIFIC DEPLETOR OF BRAIN SEROT... 1966 2026 1986 2006 1966 1966 1990 500 1000 1.5k

Peers

B. Kenneth Koe
J. David Leander United States
Robert J. Naylor United Kingdom
Thomas G. Heffner United States
Graham J. Riley United Kingdom
Barrett R. Cooper United States
C. Bræstrup Denmark
Saul Maayani United States
David T. Wong United States
J. David Leander United States
B. Kenneth Koe
Citations per year, relative to B. Kenneth Koe B. Kenneth Koe (= 1×) peers J. David Leander

Countries citing papers authored by B. Kenneth Koe

Since Specialization
Citations

This map shows the geographic impact of B. Kenneth Koe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Kenneth Koe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Kenneth Koe more than expected).

Fields of papers citing papers by B. Kenneth Koe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Kenneth Koe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Kenneth Koe. The network helps show where B. Kenneth Koe may publish in the future.

Co-authorship network of co-authors of B. Kenneth Koe

This figure shows the co-authorship network connecting the top 25 collaborators of B. Kenneth Koe. A scholar is included among the top collaborators of B. Kenneth Koe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Kenneth Koe. B. Kenneth Koe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Macor, John E., Carol B. Fox, Lorraine A. Lebel, et al.. (1994). 5-[(3-Nitropyrid-2-yl)amino]indoles: Novel Serotonin Agonists with Selectivity for the 5-HT1D Receptor. Variation of the C3 Substituent on the Indole Template Leads to Increased 5-HT1D Receptor Selectivity. Journal of Medicinal Chemistry. 37(16). 2509–2512. 27 indexed citations
2.
Koe, B. Kenneth, Lorraine A. Lebel, Carol B. Fox, & John E. Macor. (1992). Characterization of [3H]CP‐96,501 as a Selective Radioligand for the Serotonin 5‐HT1B Receptor: Binding Studies in Rat Brain Membranes. Journal of Neurochemistry. 58(4). 1268–1276. 20 indexed citations
4.
Koe, B. Kenneth, Jann A. Nielsen, John E. Macor, & James Heym. (1992). Biochemical and behavioral studies of the 5‐HT1B receptor agonist, CP‐94,253. Drug Development Research. 26(3). 241–250. 95 indexed citations
6.
Saccomano, Nicholas A., Fredric J. Vinick, B. Kenneth Koe, et al.. (1991). Calcium-independent phosphodiesterase inhibitors as putative antidepressants: [3-(bicycloalkyloxy)-4-methoxyphenyl-2-imidazolidinones. Journal of Medicinal Chemistry. 34(1). 291–298. 39 indexed citations
7.
CHENARD, B. L., Ismail A. Shalaby, B. Kenneth Koe, et al.. (1991). Separation of .alpha.1-adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compounds. Journal of Medicinal Chemistry. 34(10). 3085–3090. 130 indexed citations
8.
Lowe, John, Robert Archer, Douglas S. Chapin, et al.. (1991). Structure-activity relationship of quinazolinedione inhibitors of calcium-independent phosphodiesterase. Journal of Medicinal Chemistry. 34(2). 624–628. 77 indexed citations
9.
Sarges, Reinhard, Harry Howard, Ronald G. Browne, et al.. (1990). 4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants. Journal of Medicinal Chemistry. 33(8). 2240–2254. 358 indexed citations breakdown →
10.
Koe, B. Kenneth, Lorraine A. Lebel, & W. M. WELCH. (1990). [3H] sertraline binding to rat brain membranes. Psychopharmacology. 100(4). 470–476. 14 indexed citations
11.
Sarges, Reinhard, Harry Howard, B. Kenneth Koe, & Albert Weissman. (1989). A novel class of "GABAergic" agents: 1-aryl-3-(aminoalkylidene)oxindoles. Journal of Medicinal Chemistry. 32(2). 437–444. 60 indexed citations
12.
Schmidt, Anne W., Lorraine A. Lebel, B. Kenneth Koe, Thomas Seeger, & James Heym. (1989). Sertraline potently displaces (+)-[3H]3-PPP binding to σ sites in rat brain. European Journal of Pharmacology. 165(2-3). 335–336. 50 indexed citations
13.
Gill, Kathryn, Zalman Amit, & B. Kenneth Koe. (1988). Treatment with sertraline, a new serotonin uptake inhibitor, reduces voluntary ethanol consumption in rats. Alcohol. 5(5). 349–354. 40 indexed citations
14.
Koe, B. Kenneth, et al.. (1987). Sertraline, a selective inhibitor of serotonin uptake, induces subsensitivity of β-adrenoceptor system of rat brain. European Journal of Pharmacology. 141(2). 187–194. 32 indexed citations
15.
Koe, B. Kenneth, et al.. (1986). Enhancement of benzodiazepine binding by methaqualone and related quinazolinones. Drug Development Research. 7(3). 255–268. 12 indexed citations
16.
Welch, Willard M., Frank E. Ewing, Charles A. Harbert, Albert Weissman, & B. Kenneth Koe. (1980). 4a,9b-trans-8-Fluoro-5-(4-fluorophenyl)-2-[4-(4-fluorophenyl)-4-hydroxybutyl]-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole hydrochloride, a new potent neuroleptic. Journal of Medicinal Chemistry. 23(8). 949–952. 5 indexed citations
17.
Koe, B. Kenneth. (1976). Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain.. Journal of Pharmacology and Experimental Therapeutics. 199(3). 649–661. 447 indexed citations
18.
Koe, B. Kenneth, et al.. (1966). Clinical‐pharmacological evaluation of p‐chlorophenylalanine: A new serotonin‐depleting agent. Clinical Pharmacology & Therapeutics. 7(6). 768–776. 62 indexed citations
19.
Fox, Denis L., B. Kenneth Koe, F. J. Petracek, & L. Ƶechmeister. (1952). Some fluorescent substances contained in the marine “blood worm” (Thoracophelia mucronata). Archives of Biochemistry and Biophysics. 40(1). 135–142. 3 indexed citations
20.
Deuel, Harry J., J. Ganguly, B. Kenneth Koe, & L. Ƶechmeister. (1951). Stereoisomerization of the polycis compounds, pro-γ-carotene and prolycopene in chickens and hens. Archives of Biochemistry and Biophysics. 33(1). 143–149. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026